Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Cantor Fitzgerald
US Army

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,576,328

« Back to Dashboard

Summary for Patent: 5,576,328

Title: Method for the secondary prevention of ischemic events
Abstract:The invention relates to a new method for the secondary prevention of ischemic events comprising administering to a man in need thereof a therapeutically effective amount of a compound selected from clopidogrel and its pharmaceutically acceptable acid addition salts in association with a pharmaceutically acceptable carrier.
Inventor(s): Herbert; Jean-Marc (Tournefeuille, FR), Frehel; Daniel (Toulouse, FR), Bernat; Andr e (Cugnaux, FR), Badorc; Alain (Roquettes, FR), Savi; Pierre (Seysses, FR), Delebass ee; Denis (Goyrans, FR), Kieffer; Gilles (Montpellier, FR), Defreyn; Ghislain (Eaunes, FR), Maffrand; Jean-Pierre (Portet/Garonne, FR)
Assignee: Elf Sanofi (Paris, FR)
Application Number:08/190,332
Patent Claim Types:
see list of patent claims
Use; Composition;

No matches for this query

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: